2-aminoethylmethyl sulfone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-aminoethylmethyl sulfone: potent stimulator of ATP-dependent calcium uptake; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID Source	ID
PubMed CID	4340561
SCHEMBL ID	141464
MeSH ID	M0138651

Synonyms (37)

Synonym
BB 0254057
2-aminoethylmethyl sulfone
2-methylsulfonylethanamine
AKOS000276597
2-methanesulfonylethan-1-amine
ethanamine, 2-(methylsulfonyl)-
aems
EN300-50654
STL253420
2-(methylsulfonyl)ethanamine
49773-20-8
SCHEMBL141464
aminoethylmethylsulfone
2-(methylsulfonyl)ethylamine
2-(methylsulfonyl)-ethanamine
2-methanesulfonyl-ethylamine
2-aminoethylmethylsulfone
2-methanesulphonylethylamine
2-(methanesulphonyl)ethylamine
2-aminoethyl-methyl-sulfone
2-methanesulfonylethylamine
2-methanesulphonyl-ethylamine
2-(methylsulfonyl)ethaneamine
[2-(methylsulfonyl)ethyl]amine
mfcd01862553
2-aminoethylmethylsulphone
2-methanesulfonylethanamine
DTXSID80198035
C77681
2-(methylsulfonyl)ethan-1-amine
BS-12728
2-aminoethyl methyl sulfone
BCP09595
ZBA77320
CS-0139140
SY083342
Z265638750

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

Timeframe	Studies, This Drug (%)	All Drugs %
pre-1990	1 (14.29)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	6 (85.71)	2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.37

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

Metric	This Compound (vs All)
Research Demand Index	12.37 (24.57)
Research Supply Index	2.08 (2.92)
Research Growth Index	4.45 (4.65)
Search Engine Demand Index	0.00 (26.88)
Search Engine Supply Index	0.00 (0.95)

This Compound (12.37)

All Compounds (24.57)

Study Types

Publication Type	This drug (%)	All Drugs (%)
Trials	0 (0.00%)	5.53%
Reviews	0 (0.00%)	6.00%
Case Studies	0 (0.00%)	4.05%
Observational	0 (0.00%)	0.25%
Other	7 (100.00%)	84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Substance	Relationship Strength	Studies	Classes	Roles
chlorine chloride : A halide anion formed when chlorine picks up an electron to form an an anion.	2.6	1	halide anion; monoatomic chlorine	cofactor; Escherichia coli metabolite; human metabolite
taurine [no description available]	1.96	1	amino sulfonic acid; zwitterion	antioxidant; Escherichia coli metabolite; glycine receptor agonist; human metabolite; mouse metabolite; nutrient; radical scavenger; Saccharomyces cerevisiae metabolite
xanthenes Xanthenes: Compounds with three aromatic rings in linear arrangement with an OXYGEN in the center ring.	2.6	1	xanthene
2-aminoethylmethacrylate aminoethyl methacrylate: cell-adhesive dextran hydrogel	2.6	1	enoate ester

Condition	Relationship Strength	Studies
Chicken Pox [description not available]	2.6	1
Shingles [description not available]	2.6	1
Congenital Varicella Syndrome [description not available]	2.6	1
Chickenpox A highly contagious infectious disease caused by the varicella-zoster virus (HERPESVIRUS 3, HUMAN). It usually affects children, is spread by direct contact or respiratory route via droplet nuclei, and is characterized by the appearance on the skin and mucous membranes of successive crops of typical pruritic vesicular lesions that are easily broken and become scabbed. Chickenpox is relatively benign in children, but may be complicated by pneumonia and encephalitis in adults. (From Dorland, 27th ed)	2.6	1
Dermatitis Any inflammation of the skin.	2.6	1
Herpes Zoster An acute infectious, usually self-limited, disease believed to represent activation of latent varicella-zoster virus (HERPESVIRUS 3, HUMAN) in those who have been rendered partially immune after a previous attack of CHICKENPOX. It involves the SENSORY GANGLIA and their areas of innervation and is characterized by severe neuralgic pain along the distribution of the affected nerve and crops of clustered vesicles over the area. (From Dorland, 27th ed)	2.6	1
Hypomania [description not available]	2.6	1
Depression, Involutional Form of depression in those MIDDLE AGE with feelings of ANXIETY.	2.6	1
Depressive Disorder, Major Disorder in which five (or more) of the following symptoms have been present during the same 2-week period and represent a change from previous functioning; at least one of the symptoms is either (1) depressed mood or (2) loss of interest or pleasure. Symptoms include: depressed mood most of the day, nearly every daily; markedly diminished interest or pleasure in activities most of the day, nearly every day; significant weight loss when not dieting or weight gain; Insomnia or hypersomnia nearly every day; psychomotor agitation or retardation nearly every day; fatigue or loss of energy nearly every day; feelings of worthlessness or excessive or inappropriate guilt; diminished ability to think or concentrate, or indecisiveness, nearly every day; or recurrent thoughts of death, recurrent suicidal ideation without a specific plan, or a suicide attempt. (DSM-5)	2.6	1
Suicidal Ideation A risk factor for suicide attempts and completions, it is the most common of all suicidal behavior, but only a minority of ideators engage in overt self-harm.	2.6	1

chemdatabank.com